Wound bandage with powder

A technology of medicinal powder and wound, applied in the field of medicine, can solve the problems of allergic reaction, inappropriate size of dressing, inducing cardiovascular and cerebrovascular diseases, etc., and achieves the effect of convenient use and simple structure

Inactive Publication Date: 2016-01-06
孙桂芝
View PDF6 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Chemical synthetic drugs and bioengineering drugs are prone to toxic and side effects, such as thrombosis, inducing cardiovascular and cerebrovascular diseases, stimulating the gastrointestinal tract, causing a sharp increase in blood pressure, allergic reactions, etc.
Traditional Chinese medicines are all compound prescriptions for oral administration, so they have disadvantages such as large doses, low purity, unstable quality, and poor curative effect.
In view of the need for timely hemostasis, a hemostatic dressing that is simple in structure, easy to use, and fast for external application to stop bleeding, such as a bandage, is needed. For the hemostatic dressing at this stage, the band-aid is glued at both ends and the middle is a hemostatic dressing. The length of the band-aid with this structure Due to limitations, the size of the dressing is certain. For larger wounds, the size of the dressing is not suitable; for wounds in different positions such as thighs, arms, etc., the length of the band-aid is not enough

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Wound bandage with powder
  • Wound bandage with powder
  • Wound bandage with powder

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0022] Such as Figure 1-Figure 2 as shown, figure 1 It is a structural schematic diagram of the present invention. figure 2 It is a schematic cross-sectional structure diagram of the present invention.

[0023] The tourniquet of the present invention comprises a hemostatic dressing 3 and an adhesive layer 1, wherein the hemostatic dressing 3 is a cotton fabric, the two ends of the hemostatic dressing 3 are sewn with an adhesive layer 1, and the hemostatic dressing 3 is folded into several layers with medicinal powder arranged between the layers Layer 6, the outside of the folded hemostatic dressing 3 is wrapped with a sealed bag 2, the edge of the sealed bag 2 is provided with an adhesive layer, and the adhesive layer of the sealed bag 2 is bonded to the edge of the adhesive layer 1 to wrap the hemostatic dressing 3 in the sealed bag 2, the central part of the sealed bag 2 is integrally formed with a tear line 4, and the adhesive layer 1 is bonded with a release paper 5. T...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a wound bandage with powder. The wound bandage comprises a hemostatic dressing and bonding layers. The hemostatic dressing is made of cotton fabric. The bonding layers are sewn to two ends of the hemostatic dressing. The hemostatic dressing is folded into a plurality of layers and powder layers are arranged among the layers. A sealing bag wraps the folded hemostatic dressing. An adhesive layer is arranged at the edge of the sealing bag and is adhered to the edges of the bonding layers to enable the sealing bag to wrap the hemostatic dressing. A tearing line is arranged in the middle of the sealing bag integrally. Release paper is adhered to the bonding layers. Active ingredients of the powder layers include, by weight, 45-60g of bunge cherry seeds, 45-60g of cinnabar, 45-60g of ophicalcitum, 30-45g of the bark of ash, 30-45g of puffballs, 30-45g of longhairy antenoron herbs, 30-45g of schizonepeta, 30-45g of radix trichosanthis, 30-45g of geranium wilfordii, 30-45g of siegesbeckia orientalis, 10-20g of air potatoes, 10-20g of rhizoma nelumbinis, 10-20g of setose thistles, 10-20g of sophora flowers, 10-20g of diverse wormwood herbs, 10-20g of scutellaria baicalensis, 10-20g of gallnuts, 10-20g of peanut coats and 10-15g of liquorice. The wound bandage is simple in structure, convenient to use and capable of stopping bleeding quickly, the dressing is suitable for wounds sizes, and the bandage is suitable for wound positions.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a wound bandage with medicinal powder. Background technique [0002] Some traumatic hemorrhages require timely hemostasis. Excessive bleeding can lead to shock and life-threatening conditions. At the same time, bleeding is accompanied by pain and inflammation. If the bleeding cannot be stopped in time, it will accumulate in the body, and macrophages will swallow bacteria, causing suppuration or other diseases. Therefore, hemostatic drugs are irreplaceable and necessary products in clinical practice, and have the characteristics of strong clinical compliance. At present, hemostatic drugs mainly include traditional Chinese medicines, chemically synthesized drugs and bioengineered drugs. Chemically synthesized drugs and bioengineered drugs are prone to toxic and side effects, such as thrombosis, inducing cardiovascular and cerebrovascular diseases, stimulating the gastrointesti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61L15/40A61L15/44A61F13/02A61M35/00A61K36/8945A61P7/04A61K33/10A61K33/26A61K35/64
Inventor 孙桂芝
Owner 孙桂芝
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products